Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Transmission and prevention news

Show

From To
Questions about the PrEP implementation study

It’s a start. It’s not ideal but it’s a start.

Published
05 December 2016
From
Greg Owen (blog)
Inside The Dark, Dangerous World of Chemsex

Gay and bisexual men described wide-scale and systematic sexual violence, the deliberate drugging of vulnerable teenagers, the coaxing of impoverished men into a cloaked world of prostitution, frequent mental breakdowns from meth-induced psychoses, overdose victims routinely left to slip into comas, and a pile-up of sudden deaths. Almost no one is coming forward to report incidents to police. And most are not seeking help from services that treat substance abuse or tackle sexual exploitation.

Published
04 December 2016
From
Buzzfeed
NHS England fudges PrEP access and delays on-demand access to PrEP by years; blocks doctors from prescribing PrEP now

It is difficult to be impressed with this compromise. Rather than meet the real need of people currently at highest risk, it will further delay access to an option to prevent HIV transmission that has clearly passed the criteria for safety, efficacy and effectiveness laid out for other NHS treatments.

Published
04 December 2016
From
HIV i-Base
NHS England announces major new PrEP trial for 2017

NHS England, in collaboration with Public Health England, has announced in a press release today that a major new implementation trial of pre-exposure prophylaxis (PrEP) will start

Published
04 December 2016
By
Gus Cairns
Findings show significant progress against HIV epidemic in Africa; 90-90-90 goals in reach

National surveys in Zimbabwe, Malawi, and Zambia reveal exceptional progress against HIV, with decreasing rates of new infection, stable numbers of people living with HIV, and more than half of all those living with HIV showing viral suppression through use of antiretroviral medication. For those on antiretroviral medication, viral suppression is close to 90 percent. Thirty-five years into the global HIV epidemic, these findings are a clear sign of progress and source of hope for the rest of the world.

Published
02 December 2016
From
Eurekalert Inf Dis
PrEP: Australian advocates call for greater affordability and access to new preventative HIV method

Truvada is already listed under the pharmaceutical benefits scheme for use to treat people with HIV, but is not available for prevention. "We are incredibly keen to see this available through the PBS at scale quickly, very, very quickly," Darryl O'Donnell, CEO of the Australian Federation of AIDS Organisations said.

Published
02 December 2016
From
ABC
MP calls for PrEP manufacturer to submit to Scottish regulator

The Scottish Medicines Consortium is responsible for approving all drugs available on the NHS in Scotland and the Glasgow South MP has called for the company to make a submission, so it can form part of the country’s HIV prevention strategy.

Published
02 December 2016
From
Pink News
In the Fight against AIDS, People Who Inject Drugs Are Being Left Behind

Today, on World AIDS Day, you will repeatedly hear the mantra “leave no one behind,” referring to the concerted effort to end AIDS by 2030 pledged in the UN’s Sustainable Development Goals. But evidence shows that people who use drugs, a population at particular risk of HIV transmission, are in fact being left further and further behind.

Published
02 December 2016
From
Open Society Foundations
Refuelling the global HIV response: the role of the United Kingdom

On the eve of World AIDS Day, STOPAIDS, with support from the United Kingdom All-Party Parliamentary Group on HIV & AIDS, organized an event to discuss the role of the United Kingdom in the global AIDS response.

Published
02 December 2016
From
UNAIDS
Survey finds good knowledge of PrEP in Europe and a considerable amount of unsupported informal PrEP use

A large survey of knowledge and use of pre-exposure prophylaxis (PrEP) in Europe released its preliminary results on World AIDS Day. The Flash! PrEP in Europe survey

Published
01 December 2016
By
Gus Cairns

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.